Advertisement

Topics

Global Human Combination Vaccines Market to Grow at a CAGR of 9% Through 2021, Announces Technavio

15:03 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
The global human combination vaccines market is expected to grow at a CAGR of close to 9% during the forecast period, according to Technavio’s latest market research. This Smart News Release features multimedia. View the...

Other Sources for this Article

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770
www.technavio.com

NEXT ARTICLE

More From BioPortfolio on "Global Human Combination Vaccines Market to Grow at a CAGR of 9% Through 2021, Announces Technavio"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...